ACAD
34.31
-0.67
-1.92%
AEMD
4.93
-0.18
-3.52%
APRI
0.34
-0.01
-2.7166%
ARNA
1.75
+0.01
+0.57%
ATEC
8.25
-0.38
-4.40%
CNAT
2.109
-0.001
-0.0379%
CRXM
0.26
-0.01
-3.70%
CYTX
2.037
-0.083
-3.9340%
DXCM
93.39
-0.52
-0.55%
GNMK
11.67
-0.03
-0.26%
HALO
11.98
-0.11
-0.91%
ILMN
178.47
-0.86
-0.48%
INNV
0.275
-0.005
-1.7500%
INO
9.44
-0.06
-0.63%
ISCO
1.815
-0.085
-4.474%
ISIS
57.56
0.00
0.00%
LGND
113.29
-2.49
-2.15%
LPTN
3.774
-0.116
-2.9872%
MBVX
4.285
-0.435
-9.216%
MEIP
1.73
+0.04
+2.37%
MNOV
7.48
+0.38
+5.35%
MRTX
6.21
+0.33
+5.61%
MSTX
0.124
-0.004
-2.7473%
NBIX
53.25
-0.69
-1.28%
NUVA
66.35
-0.42
-0.63%
ONCS
1.77
-0.01
-0.56%
ONVO
3.91
-0.06
-1.51%
OREX
3.28
-0.18
-5.1994%
OTIC
17.17
-0.48
-2.72%
QDEL
22.125
-0.585
-2.576%
RCPT
231.96
0.00
0.00%
RGLS
3.385
-0.065
-1.884%
RMD
63.7
+0.45
+0.71%
SPHS
3.18
+0.22
+7.43%
SRNE
7.68
-0.09
-1.16%
TROV
4.63
-0.16
-3.34%
VICL
3.22
-0.03
-0.92%
VOLC
18
0.00
0.00%
ZGNX
10.43
-0.02
-0.19%
ACAD
34.31
-0.67
-1.92%
AEMD
4.93
-0.18
-3.52%
APRI
0.34
-0.01
-2.7166%
ARNA
1.75
+0.01
+0.57%
ATEC
8.25
-0.38
-4.40%
CNAT
2.109
-0.001
-0.0379%
CRXM
0.26
-0.01
-3.70%
CYTX
2.037
-0.083
-3.9340%
DXCM
93.39
-0.52
-0.55%
GNMK
11.67
-0.03
-0.26%
HALO
11.98
-0.11
-0.91%
ILMN
178.47
-0.86
-0.48%
INNV
0.275
-0.005
-1.7500%
INO
9.44
-0.06
-0.63%
ISCO
1.815
-0.085
-4.474%
ISIS
57.56
0.00
0.00%
LGND
113.29
-2.49
-2.15%
LPTN
3.774
-0.116
-2.9872%
MBVX
4.285
-0.435
-9.216%
MEIP
1.73
+0.04
+2.37%
MNOV
7.48
+0.38
+5.35%
MRTX
6.21
+0.33
+5.61%
MSTX
0.124
-0.004
-2.7473%
NBIX
53.25
-0.69
-1.28%
NUVA
66.35
-0.42
-0.63%
ONCS
1.77
-0.01
-0.56%
ONVO
3.91
-0.06
-1.51%
OREX
3.28
-0.18
-5.1994%
OTIC
17.17
-0.48
-2.72%
QDEL
22.125
-0.585
-2.576%
RCPT
231.96
0.00
0.00%
RGLS
3.385
-0.065
-1.884%
RMD
63.7
+0.45
+0.71%
SPHS
3.18
+0.22
+7.43%
SRNE
7.68
-0.09
-1.16%
TROV
4.63
-0.16
-3.34%
VICL
3.22
-0.03
-0.92%
VOLC
18
0.00
0.00%
ZGNX
10.43
-0.02
-0.19%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.